Dr Reddys Valuation

RDY -- USA Stock  

USD 38.01  1.10  2.81%

Dr Reddys Laboratories owns latest Real Value of $47.09 per share. The recent price of the firm is $38.01. At this time the firm appears to be undervalued. This module computes value of Dr Reddys Laboratories from reviewing the firm fundamentals such as Shares Outstanding of 165.72M, Number of Shares Shorted of 1.68M and Return On Asset of 5.42% as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to invest in undervalued equities and to sell out overvalued equities since in the future instruments prices and their ongoing real values will draw towards each other.
September 22, 2019
Market Value
Real Value
Dr Reddys is very steady asset. Calculation of real value of Dr Reddys Laboratories is based on 3 months time horizon. Increasing Dr Reddys Laboratories time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Horizon     30 Days    Login   to change
Dr Reddys Laboratories Ltd is rated below average in price to book category among related companies. It is rated fourth in five year return category among related companies reporting about  0.22  of Five Year Return per Price to Book. The ratio of Price to Book to Five Year Return for Dr Reddys Laboratories Ltd is roughly  4.56 

Valuation Basics

Dr Reddys Enterprise Value Fundamentals

Quick Ratio1.10
Earnings Quarterly Growth45.30%
Revenue Growth3.30%
Payout Ratio15.98%
Earnings Growth45.40%
Additionally take a look at Your Equity Center. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Search macroaxis.com